Steve Madden

Steve Madden's work experience began in 2001 at Cumbre Pharmaceuticals Inc., where they worked as a Quality Assurance Manager until 2008. In 2008, they joined Sovereign Pharmaceuticals as a Regulatory Affairs Manager for a few months. From 2008 to 2011, Steve worked at Reata Pharmaceuticals, first as a Sr. Manager in Regulatory Affairs and Quality Assurance, and then as an Associate Director in Quality Assurance.

In 2014, they joined Peloton Therapeutics as a Quality Assurance Manager. Steve later took on roles as an Associate Director in Quality Assurance and Regulatory Affairs, and then as a Director in Regulatory Affairs. Steve worked at Peloton Therapeutics until 2020.

In 2020, Steve joined NiKang Therapeutics Inc. as the Executive Director in Regulatory Affairs, QA, and QC. Steve later became the VP in Regulatory Affairs and Quality Assurance. Steve briefly left NiKang Therapeutics in 2022 to work as a Regulatory Affairs and Quality Assurance Consultant at Dose Therapeutics, Inc.

In 2022, Steve returned to Dose Therapeutics, Inc. as the VP in Regulatory Affairs and Quality Assurance. Steve then moved to their current role at NiKang Therapeutics Inc. as the VP in Regulatory Affairs and Quality Assurance starting from March 2023.

Overall, Steve Madden has held a variety of roles in the pharmaceutical industry, focusing on regulatory affairs and quality assurance.

Steve Madden completed their Bachelor's degree in Chemistry from Texas A&M University, where they studied from 1989 to 1993.